Comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors

AT Podany, KK Scarsi, CV Fletcher - Clinical pharmacokinetics, 2017 - Springer
Abstract Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL) are members of the
latest class of antiretrovirals (ARVs) that have become available to treat human …

Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors

AT Podany, KK Scarsi… - Clinical …, 2017 - experts.nebraska.edu
Abstract Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL) are members of the
latest class of antiretrovirals (ARVs) that have become available to treat human …

Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors

AT Podany, KK Scarsi, CV Fletcher - Clinical Pharmacokinetics, 2016 - infona.pl
Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL) are members of the latest class
of antiretrovirals (ARVs) that have become available to treat human immunodeficiency virus …

Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors

AT Podany, KK Scarsi… - Clinical …, 2017 - search.proquest.com
INSTIs are potent inhibitors of the HIV integrase enzyme, with protein binding-adjusted
concentration inhibiting viral replication by 90/95%[IC90/95] values in the low nanogram per …

[HTML][HTML] Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors

AT Podany, KK Scarsi, CV Fletcher - pillintrip.com
Abstract Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL), are members of latest
class of antiretrovirals (ARV) available to treat human immunodeficiency virus (HIV) …

[HTML][HTML] Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors

AT Podany, KK Scarsi, CV Fletcher - Clinical pharmacokinetics, 2017 - ncbi.nlm.nih.gov
Abstract Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL), are members of latest
class of antiretrovirals (ARV) available to treat human immunodeficiency virus (HIV) …

Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.

AT Podany, KK Scarsi, CV Fletcher - Clinical Pharmacokinetics, 2017 - europepmc.org
Abstract Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL), are members of latest
class of antiretrovirals (ARV) available to treat human immunodeficiency virus (HIV) …

Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors

AT Podany, KK Scarsi… - Clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL) are members of the latest class
of antiretrovirals (ARVs) that have become available to treat human immunodeficiency virus …

Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.

AT Podany, KK Scarsi, CV Fletcher - Clinical Pharmacokinetics, 2017 - europepmc.org
Abstract Dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL), are members of latest
class of antiretrovirals (ARV) available to treat human immunodeficiency virus (HIV) …